Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyline with Testosterone and DMPA for Male Contraception
NCT00161447Phase 2Completed
- Sponsor
- University of Washington
- Start
- May 2004
- Primary completion
- Apr 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acyline in male contraception (2 arms), sponsored by University of Washington. Primary endpoints: Suppression of spermatogenesis at 1 year, Suppression of gonadotropins at 1 year and 3 more. Started May 2004; status: completed.
02
Drugs
acyline
03
Conditions
male contraception
Beyond the preview
Go deeper on NCT00161447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161447.